›››
Loading...
Loading...
Pfizer — Model a full Wheel cycle: CSP entry, assignment, and CC exit
Pfizer (PFE) operates in the Health Care sector and has actively traded listed options. The wheel ties up $2,800 per contract in a CSP that needs rich premiums to justify the commitment. IV Rank at 24.8% keeps premiums below the sweet spot. Marginal — wait for IV expansion or size down. VRP is -0.6pp. See Covered Call for strike comparisons.
Wheel Cycle
Capital: ~$2,828Unfavorable — 3 conditions flagged
The Wheel strategy cycles between selling puts and covered calls. This page evaluates whether the current setup favors starting a Wheel position on this ticker.
Check if you'd be comfortable owning the stock at the put strike — that's the key Wheel decision.
Combines: capital requirement, IV Rank, VRP, signal strength, premium environment, liquidityStock price (for capital calc), IV Rank, VRP, bid-ask spreads, open interest
ORATS options data + VolRadar signal composite
The Wheel requires willingness to own shares at the put strike. Assignment risk is real — stock can drop significantly below your strike. Capital requirements vary with stock price.
After assignment on your cash secured put, the options wheel transitions to selling covered calls. These are the best current covered call opportunities to reduce cost basis:
Already own PFE shares from a cash secured put assignment? These covered call and hedge strategies work with your existing position to generate income or protect gains.
Own shares + sell OTM call — generate income from existing position.
Same as Short Put but with full cash to buy shares at strike if assigned.
Buy deep ITM LEAPS call + sell short-term OTM call — like covered call but less capital.
Quantitative screening, not investment advice. Verify with your broker. Disclaimer
At the current price, wheeling Pfizer requires approximately $2,700 per contract — an accessible entry for most accounts. Lower capital requirements allow running multiple wheel positions simultaneously across different tickers, improving diversification. Start with a single contract to learn the mechanics before scaling.
Pfizer's premium environment is lean with IV Rank at 25%. In low-IV conditions, wheel premiums are thinner — each CSP or CC cycle generates less income. Consider tighter strikes (closer to ATM) to maintain yield, but be aware this increases assignment probability. Some wheel traders pause new entries in lean environments and wait for IV expansion.
Pfizer's current signal is weak, suggesting conditions are unfavorable for new wheel entries. Options may be fairly priced or underpriced relative to expected movement. Consider waiting for the signal to improve, or if already in a wheel cycle, manage existing positions conservatively with wider strikes.
Free embeddable tool: Wheel Calculator — add wheel strategy analysis to any site. No signup, no API key.
All P/L calculations exclude commissions, fees, and slippage. Premiums are model estimates (not live quotes) — verify with broker. Actual returns may differ significantly.
100 shares × $27 strike · On margin (~20%): ~$540
Sell call at or above cost basis ($26.17) to ensure profit if called away.
Assumes assignment at expiration. American-style options may be assigned early, especially near ex-dividend dates or deep ITM.
Cash-secured: $2,700 per contract (100 shares x $27 strike). On margin (~20% requirement): approximately $540. Follow the 5% rule — no single wheel position should exceed 5% of your total account.
Most wheel traders sell puts 5–10% below current price (0.20–0.30 delta). For PFE at $28.28, that means selling puts around $27–$25. In higher IV environments, you can sell further OTM while still collecting meaningful premium.
If assigned, you buy 100 shares at the put strike price. Your effective cost basis equals the strike minus premium collected (e.g., $27 - premium). Move to Phase 2: sell covered calls at or above your cost basis. Each call premium further reduces your cost basis.
Annualized returns vary with IV conditions. Under favorable conditions, experienced wheel traders may target 15–30% annualized. Conservative 5% OTM strikes with 30–45 DTE tend to yield 12–20% annualized in normal conditions. The key variables are IV Rank (higher = richer premiums), strike distance (closer = more premium but higher assignment risk), and DTE (30–45 days is the theta decay sweet spot).
The biggest risk is assignment into a declining stock. If Pfizer drops sharply below your put strike, you own 100 shares at a loss — and subsequent covered calls may not generate enough premium to recover before the stock falls further. At Pfizer's current price of $28.28, assignment means holding $2,700 in a single position. Current negative VRP suggests options are underpricing actual movement, which means the premium collected may not adequately compensate for assignment risk. To manage this: size each wheel to no more than 5% of your account, avoid selling CSPs into earnings, and confirm a positive VRP edge before entering.
Pfizer currently shows weak conditions for premium selling. Consider waiting for the signal to improve before starting a new wheel. If already in a wheel cycle, manage existing positions conservatively.